XML 39 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Investment in Subsidiaries - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2011
Jan. 31, 2011
Preferred Stock B and C [Member]
Dec. 31, 2012
Calando Pharmaceuticals, Inc. [Member]
Jan. 31, 2011
Calando Pharmaceuticals, Inc. [Member]
Sep. 30, 2011
Ablaris Therapeutics, Inc. [Member]
Dec. 31, 2012
Ablaris Therapeutics, Inc. [Member]
Dec. 31, 2012
Leonardo Biosystems, Inc. [Member]
Schedule of Investments [Line Items]                
Ownership percentage in subsidiary 100.00%              
Investment in preferred stock     $ 9,100,000     $ 1,300,000    
Cash investment in subsidiary         1,000,000      
Investment in subsidiary through conversion of intercompany debt         8,100,000      
Amount owed by subsidiary       3,500,000       575,000
Stated percentage of notes and advances       800000000.00%        
Percentage of outstanding shares       7900.00%     64.00% 3.00%
Percentage of investment ownership       76.00%     64.00%  
Aggregate purchase price of preferred shares   (1,618,509)       2,900,000    
Investment in preferred stock by outsider           $ 1,600,000